Glycogen Storage Disease Type I.
Bali DS, El-Gharbawy A, Austin S, Pendyal S, Kishnani PS.
2006 Apr 19 [updated 2021 Oct 14]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Von Willebrand Disease.
Johnsen J.
2009 Jun 4 [updated 2024 Nov 14]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Hereditary haemorrhagic telangiectasia.
Sharathkumar AA, Shapiro A.
Haemophilia. 2008 Nov;14(6):1269-80. doi: 10.1111/j.1365-2516.2008.01774.x.
Epistaxis in children: causes, diagnosis, and treatment.
Guarisco JL, Graham HD 3rd.
Ear Nose Throat J. 1989 Jul;68(7):522, 528-30, 532 passim.
Intranasal encephaloceles.
Blumenfeld R, Skolnik EM.
Arch Otolaryngol. 1965 Nov;82(5):527-31. doi: 10.1001/archotol.1965.00760010529015.
An unusual case of epistaxis in a four month old.
Robinson AE, Robinson JD, Strobel AM, Wagner EA, Smith SW.
Am J Emerg Med. 2021 Sep;47:228-230. doi: 10.1016/j.ajem.2021.04.035. Epub 2021 Apr 17.
Risk of cancer in patients with epistaxis and haemoptysis.
Ording AG, Veres K, Farkas DK, Adelborg K, Sørensen HT.
Br J Cancer. 2018 Mar 20;118(6):913-919. doi: 10.1038/bjc.2017.494. Epub 2018 Feb 20.
Pattern of epistaxis in Sokoto, Nigeria: a review of 72 cases.
Iseh KR, Muhammad Z.
Ann Afr Med. 2008 Sep;7(3):107-11. doi: 10.4103/1596-3519.55668.
Epistaxis: The demographics, etiology, management, and predictors of outcome in Jos, North-Central Nigeria.
Adoga AA, Kokong DD, Mugu JG, Okwori ET, Yaro JP.
Ann Afr Med. 2019 Apr-Jun;18(2):75-79. doi: 10.4103/aam.aam_24_18.
Factor XIII deficiency in the Saudi population, an underestimated bleeding risk. Review article and an illustrative case report with dental complications.
Aljabry M.
Saudi Dent J. 2023 May;35(4):305-309. doi: 10.1016/j.sdentj.2023.03.015. Epub 2023 Apr 5.
